{
     "PMID": "10678833",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20000306",
     "LR": "20131121",
     "IS": "0036-8075 (Print) 0036-8075 (Linking)",
     "VI": "287",
     "IP": "5456",
     "DP": "2000 Feb 18",
     "TI": "Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.",
     "PG": "1265-9",
     "AB": "To elucidate the role of the synaptic protein alpha-synuclein in neurodegenerative disorders, transgenic mice expressing wild-type human alpha-synuclein were generated. Neuronal expression of human alpha-synuclein resulted in progressive accumulation of alpha-synuclein-and ubiquitin-immunoreactive inclusions in neurons in the neocortex, hippocampus, and substantia nigra. Ultrastructural analysis revealed both electron-dense intranuclear deposits and cytoplasmic inclusions. These alterations were associated with loss of dopaminergic terminals in the basal ganglia and with motor impairments. These results suggest that accumulation of wild-type alpha-synuclein may play a causal role in Parkinson's disease and related conditions.",
     "FAU": [
          "Masliah, E",
          "Rockenstein, E",
          "Veinbergs, I",
          "Mallory, M",
          "Hashimoto, M",
          "Takeda, A",
          "Sagara, Y",
          "Sisk, A",
          "Mucke, L"
     ],
     "AU": [
          "Masliah E",
          "Rockenstein E",
          "Veinbergs I",
          "Mallory M",
          "Hashimoto M",
          "Takeda A",
          "Sagara Y",
          "Sisk A",
          "Mucke L"
     ],
     "AD": "Department of Neurosciences, Department of Pathology, University of California San Diego, La Jolla, CA 92093-0624, USA. emasliah@ucsd.edu",
     "LA": [
          "eng"
     ],
     "GR": [
          "AG10689/AG/NIA NIH HHS/United States",
          "AG11385/AG/NIA NIH HHS/United States",
          "AG5131/AG/NIA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't",
          "Research Support, U.S. Gov't, P.H.S."
     ],
     "PL": "United States",
     "TA": "Science",
     "JT": "Science (New York, N.Y.)",
     "JID": "0404511",
     "RN": [
          "0 (Nerve Tissue Proteins)",
          "0 (SNCA protein, human)",
          "0 (Snca protein, mouse)",
          "0 (Synucleins)",
          "0 (Ubiquitins)",
          "0 (alpha-Synuclein)",
          "EC 1.14.16.2 (Tyrosine 3-Monooxygenase)",
          "VTD58H1Z2X (Dopamine)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Brain/*metabolism/ultrastructure",
          "Dopamine/*physiology",
          "Humans",
          "Inclusion Bodies/*metabolism/ultrastructure",
          "Lewy Bodies/ultrastructure",
          "Lewy Body Disease/metabolism/pathology",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Inbred DBA",
          "Mice, Transgenic",
          "Microscopy, Electron",
          "Motor Activity",
          "Nerve Tissue Proteins/genetics/immunology/*metabolism",
          "Neurodegenerative Diseases/*metabolism/pathology",
          "Neurons/*metabolism/ultrastructure",
          "Substantia Nigra/metabolism/ultrastructure",
          "Synucleins",
          "Tyrosine 3-Monooxygenase/immunology/metabolism",
          "Ubiquitins/metabolism",
          "alpha-Synuclein"
     ],
     "EDAT": "2000/02/26 09:00",
     "MHDA": "2000/03/11 09:00",
     "CRDT": [
          "2000/02/26 09:00"
     ],
     "PHST": [
          "2000/02/26 09:00 [pubmed]",
          "2000/03/11 09:00 [medline]",
          "2000/02/26 09:00 [entrez]"
     ],
     "AID": [
          "8276 [pii]"
     ],
     "PST": "ppublish",
     "SO": "Science. 2000 Feb 18;287(5456):1265-9.",
     "term": "hippocampus"
}